Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/− cetuximab in oesophageal cancer

Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/− cetuximab in oesophageal cancer

The SCOPE-1 study tested the role of adding cetuximab to conventional definitive chemoradiotherapy (dCRT), and demonstrated greater toxicity and worse survival outcomes. We present the long-term outcomes and patterns of recurrence.SCOPE-1 was a phase II/III trial in which patients were randomised to...

书目详细资料
Main Authors:	Crosby, T, Hurt, C, Falk, S, Gollins, S, Staffurth, J, Ray, R, Bridgewater, J, Geh, J, Cunningham, D, Blazeby, J, Roy, R, Maughan, T, Griffiths, G, Mukherjee, S
格式:	Journal article
语言:	English
出版:	Springer Nature 2017

相似书籍

Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial.
由: Crosby, T, et al.
出版: (2013)

Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial.
由: Mukherjee, S, et al.
出版: (2013)

Can protons reduce bone marrow toxicity in definitive chemoradiotherapy for oesophageal tumours?
由: Warren, S, et al.
出版: (2016)

Oesophageal Chemoradiotherapy in the UK-Current Practice and Future Directions
由: Gwynne, S, et al.
出版: (2013)

Oesophageal Chemoradiotherapy in the UK--current practice and future directions.
由: Gwynne, S, et al.
出版: (2013)

NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma
由: Mukherjee, S, et al.
出版: (2017)

Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer
由: Hurt, C, et al.
出版: (2017)

Definitive chemoradiation in patients with inoperable oesophageal carcinoma.
由: Crosby, T, et al.
出版: (2004)

The influence of dose distribution on treatment outcome in the SCOPE 1 oesophageal cancer trial
由: Carrington, E, et al.
出版: (2016)

Patterns of recurrence after definitive chemo-radiotherapy for oesophageal carcinoma
由: Button, MR, et al.
出版: (2007)

NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma.
由: Mukherjee, S, et al.
出版: (2015)

NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma.
由: Mukherjee, S, et al.
出版: (2015)

Efficacy of early PET-CT directed switch to carboplatin and paclitaxel based definitive chemoradiotherapy in patients with oesophageal cancer who have a poor early response to induction cisplatin and capecitabine in the UK: a multi-centre randomised controlled phase II trialResearch in context
由: Somnath Mukherjee, et al.
出版: (2023-07-01)

The effect of dose escalation on gastric toxicity when treating lower oesophageal tumours: A radiobiological investigation
由: Carrington, R, et al.
出版: (2015)

Small cell oesophageal carcinoma: an institutional experience and review of the literature.
由: Hudson, E, et al.
出版: (2007)

Driving developments in UK oesophageal radiotherapy through the SCOPE trials
由: S. Gwynne, et al.
出版: (2019-02-01)

Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Patients Treated with Definitive Chemoradiotherapy for Locally Advanced Oesophageal Squamous Cell Carcinoma
由: Zhang G, et al.
出版: (2023-01-01)

Analysis of clinical outcomes and prognostic factors in patients treated with definitive chemoradiotherapy for oesophageal squamous cell carcinoma
由: Hyehyun Jeong, et al.
出版: (2021-03-01)

Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): Long-term results of a multicentre, randomised, controlled, phase 3 trial
由: Bridgewater, JA, et al.
出版: (2020)

Imaging biomarkers of contrast-enhanced computed tomography predict survival in oesophageal cancer after definitive concurrent chemoradiotherapy
由: Chengbing Zeng, et al.
出版: (2021-01-01)

Chemoradiotherapy for carcinoma of the oesophagus: Experience of a single institution
由: Toy, E, et al.
出版: (2001)

Use of a non-endoscopic immunocytological device (Cytosponge™) for post chemoradiotherapy surveillance in patients with oesophageal cancer in the UK (CYTOFLOC): A multicentre feasibility study
由: Christopher M. Jones, et al.
出版: (2022-11-01)

Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: the phase 1/randomised phase 2 SCALOP-2 trial
由: Mukherjee, S, et al.
出版: (2024)

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial.
由: Maughan, T, et al.
出版: (2011)

Effect of anaemia prevention on survival and local control in oesophageal cancers treated with chemoradiotherapy.
由: Tuan, J, et al.
出版: (2012)

Concurrent chemoradiotherapy for cardiac metastasis after oesophageal carcinoma resection
由: Y. Hama, et al.
出版: (2023-12-01)

A qualitative study exploring participants’ experiences of the SCOPE2 trial: chemoradiotherapy dose escalation in oesophageal cancer
由: Daniella Holland-Hart, et al.
出版: (2025-02-01)

The experiences of patients with oesophageal cancer receiving chemoradiotherapy treatment: a qualitative study embedded in the SCOPE2 trial
由: Mirella Longo, et al.
出版: (2024-09-01)

Cetuximab plus Irinotecan as third line chemotherapy for metastatic colorectal cancer
由: Moe, M, et al.
出版: (2008)

Cetuximab therapy in first-line metastatic colorectal cancer and intermittent palliative chemotherapy: review of the COIN trial.
由: Adams, R, et al.
出版: (2008)

A prospective comparison of multidisciplinary treatment of oesophageal cancer with curative intent in a UK cancer network.
由: Adams, R, et al.
出版: (2007)

Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial.
由: Dutton, S, et al.
出版: (2014)

Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: a case–control study
由: Yang Li, et al.
出版: (2017-08-01)

Survival after curative chemoradiotherapy or neoadjuvant therapy and surgery converges in higher-risk patients with oesophageal cancer
由: Rana, M, et al.
出版: (2021)

The effectiveness of neoadjuvant chemoradiotherapy in oesophageal adenocarcinoma with presence of extracellular mucin, signet‐ring cells, and/or poorly cohesive cells
由: Maria J Valkema, et al.
出版: (2023-07-01)

Addition of cetuximab to oxaliplatin-based combination chemotherapy (CT) in patients with KRAS wild-type advanced colorectal cancer (ACRC): a randomised superiority trial (MRC COIN)
由: Maughan, T, et al.
出版: (2009)

Squamous carcinoma in an oesophageal foregut cyst
由: Jacob, R, et al.
出版: (2003)

A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS
由: Gollins, S, et al.
出版: (2019)

Discovery of stable and prognostic CT-based radiomic features independent of contrast administration and dimensionality in oesophageal cancer.
由: Concetta Piazzese, et al.
出版: (2019-01-01)

Machine learning model for predicting excessive muscle loss during neoadjuvant chemoradiotherapy in oesophageal cancer
由: Han Gyul Yoon, et al.
出版: (2021-10-01)